2014 ACBS Landline-Cellphone Combined Prevalence Tables
TABLE 3b. Estimated percent for time since first diagnosis among adults1 with active2 asthma by state/territory – BRFSS Asthma Call-back Survey Land Line And Cell Phone Combined Sample, United States, 2014
| State/Territory | Sample size± |
5 or fewer years | More than 5 years | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Sample size |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | ||
| Connecticut | 225 | 23 | 11.5 | 3.3 | (5.0 – 18.0) | 202 | 88.5 | 3.3 | (82.0 – 95.0) |
| District of Columbia | 112 | 10 | N/A | N/A | (N/A – N/A) | 102 | 94.0 | 2.6 | (88.9 – 99.1) |
| Georgia | 137 | 22 | N/A | N/A | (N/A – N/A) | 115 | 81.7 | 6.9 | (68.2 – 95.2) |
| Hawaii | 196 | 17 | N/A | N/A | (N/A – N/A) | 179 | 90.7 | 3.1 | (84.6 – 96.8) |
| Illinois | 202 | 21 | 9.0 | 2.6 | (3.9 – 14.1) | 181 | 91.0 | 2.6 | (85.9 – 96.1) |
| Indiana | 512 | 59 | 10.4 | 2.0 | (6.5 – 14.3) | 453 | 89.6 | 2.0 | (85.7 – 93.5) |
| Iowa | 253 | 36 | 12.4 | 2.7 | (7.1 – 17.7) | 217 | 87.6 | 2.7 | (82.3 – 92.9) |
| Maine | 312 | 35 | 17.2 | 3.9 | (9.6 – 24.8) | 277 | 82.8 | 3.9 | (75.2 – 90.4) |
| Maryland | 220 | 25 | 10.3 | 2.6 | (5.2 – 15.4) | 195 | 89.7 | 2.6 | (84.6 – 94.8) |
| Michigan | 450 | 51 | 11.9 | 2.4 | (7.2 – 16.6) | 399 | 88.1 | 2.4 | (83.4 – 92.8) |
| Mississippi | 137 | 16 | N/A | N/A | (N/A – N/A) | 121 | 93.1 | 2.3 | (88.6 – 97.6) |
| Missouri | 260 | 32 | 13.6 | 3.4 | (6.9 – 20.3) | 228 | 86.4 | 3.4 | (79.7 – 93.1) |
| Montana | 264 | 30 | N/A | N/A | (N/A – N/A) | 234 | 88.1 | 3.8 | (80.7 – 95.5) |
| Nebraska | 723 | 96 | 12.7 | 2.2 | (8.4 – 17.0) | 627 | 87.3 | 2.2 | (83.0 – 91.6) |
| Nevada | 151 | 18 | N/A | N/A | (N/A – N/A) | 133 | 90.7 | 3.0 | (84.8 – 96.6) |
| New Hampshire | 229 | 22 | N/A | N/A | (N/A – N/A) | 207 | 87.0 | 5.0 | (77.2 – 96.8) |
| New Jersey | 448 | 71 | 14.7 | 2.2 | (10.4 – 19.0) | 377 | 85.3 | 2.2 | (81.0 – 89.6) |
| New Mexico | 258 | 39 | 14.0 | 3.2 | (7.7 – 20.3) | 219 | 86.0 | 3.2 | (79.7 – 92.3) |
| New York | 120 | 11 | N/A | N/A | (N/A – N/A) | 109 | 89.9 | 5.2 | (79.7 – 100.0) |
| North Carolina | 137 | 21 | 15.4 | 4.6 | (6.4 – 24.4) | 116 | 84.6 | 4.6 | (75.6 – 93.6) |
| Ohio | 355 | 49 | 11.1 | 2.2 | (6.8 – 15.4) | 306 | 88.9 | 2.2 | (84.6 – 93.2) |
| Oklahoma | 219 | 18 | 7.9 | 2.2 | (3.6 – 12.2) | 201 | 92.1 | 2.2 | (87.8 – 96.4) |
| Oregon | 193 | 19 | N/A | N/A | (N/A – N/A) | 174 | 91.1 | 2.7 | (85.8 – 96.4) |
| Pennsylvania | 430 | 55 | 14.8 | 2.7 | (9.5 – 20.1) | 375 | 85.2 | 2.7 | (79.9 – 90.5) |
| Rhode Island | 212 | 42 | 21.9 | 5.2 | (11.7 – 32.1) | 170 | 78.1 | 5.2 | (67.9 – 88.3) |
| Texas | 527 | 75 | 13.8 | 2.6 | (8.7 – 18.9) | 452 | 86.2 | 2.6 | (81.1 – 91.3) |
| Utah | 546 | 65 | 12.5 | 1.9 | (8.8 – 16.2) | 481 | 87.5 | 1.9 | (83.8 – 91.2) |
| Vermont | 253 | 33 | 12.0 | 2.6 | (6.9 – 17.1) | 220 | 88.0 | 2.6 | (82.9 – 93.1) |
| Washington | 389 | 46 | N/A | N/A | (N/A – N/A) | 343 | 87.7 | 3.9 | (80.1 – 95.3) |
| West Virginia | 233 | 41 | 16.2 | 3.1 | (10.1 – 22.3) | 192 | 83.8 | 3.1 | (77.7 – 89.9) |
| Wisconsin | 254 | 33 | 9.8 | 2.1 | (5.7 – 13.9) | 221 | 90.2 | 2.1 | (86.1 – 94.3) |
| Puerto Rico | 390 | 62 | 15.4 | 2.3 | (10.9 – 19.9) | 328 | 84.6 | 2.3 | (80.1 – 89.1) |
| 32 state total | 9,347 | 1,193 | 12.3 | 0.9 | (10.5 – 14.1) | 8,154 | 87.7 | 0.9 | (85.9 – 89.5) |
| Median | 12.6 | 87.9 | |||||||
| Range | 7.9-21.9 | 78.1-94.0 | |||||||
1 Aged ≥ 18 years
2 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30
Page last reviewed: February 14, 2017